New Delhi: The popular anti-diabetes drug Pioglitazone would soon be available in the market as the Union Health Ministry has decided to revoke the ban on its sale and manufacture with some riders. The drug, used by lakhs of diabetes patients in the country, would be sold with a warning and would not be used as the first line of treatment. The drug was banned by the Ministry on June 18. A notification lifting the ban will be issued soon, official sources said.
Excessive cell phone use linked to cancer, genetic mutations
Robotic surgery to cure apnea beamed live to doctors worldwide